Elsevier

The Lancet

Volume 340, Issue 8825, 17 October 1992, Pages 930-932
The Lancet

ORIGINAL ARTICLES
Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease

https://doi.org/10.1016/0140-6736(92)92816-XGet rights and content

Abstract

Infection of the gastric antrum by Helicobacter pylori is associated with recurrent duodenal ulcer disease but the mechanism of ulcerogenesis is unclear. Since pathways inhibiting gastric secretion are defective in patients with duodenal ulcers, we investigated whether H pylori interferes with the normal gastric inhibition that is mediated by somatostatin. We studied 28 patients with active duodenal ulcers in whom H pylori was eradicated successfully. In 18 patients, we measured the density of antral somatostatin-immunoreactive cells and in a further 10 subjects, the amount of somatostatin mRNA before and after eradication of H pylori was determined. After eradication, the median density of somatostatin-immunoreactive cells increased significantly from 9 (range 3-47) to 19 (6-57) cells per mm muscularis mucosa (p=0·025). The median somatostatin mRNA/rRNA ratio increased from 50 (25-160) to 95 (40-180) (p=0·01). The number of gastrin cells and quantity of gastrin mRNA did not change significantly. Our results suggest that in duodenal ulcer disease, gastric secretory function is disinhibited through the suppression of mucosal somatostatin.

References (24)

  • S. Levi et al.

    Antral Campylobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism

    BMJ

    (1989)
  • Cited by (285)

    • Mechanisms of Helicobacter pylori-Induced Gastric Inflammation

      2018, Physiology of the Gastrointestinal Tract, Sixth Edition
    • Redox signaling in the gastrointestinal tract

      2017, Free Radical Biology and Medicine
      Citation Excerpt :

      This is due to H. pylori urease activity that produces ammonia from urea, which neutralizes HCl on the gastric mucosa. As a result, an inadequate amount of somatostatin is released increasing gastrin release and acid production by gastric mucosa [159,160]. Furthermore, H. pylori releases chemotactic factors, such as N-formyl-methionyl-leucyl phenylalanine peptide, and causes an inflammatory response in gastric mucosa, promoting IL-8 and IL-1β release from gastric epithelial cells [161,162].

    • Helicobacter pylori and Other Gastric Helicobacter Species

      2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
    • Regulation of Gastric Acid Secretion

      2012, Physiology of the Gastrointestinal Tract
    • Peptic ulcer disease

      2017, The Lancet
    View all citing articles on Scopus
    View full text